Monday, Sept. 29, 2008 | Bio-ITWorld.com | Archives | Advertising | Your Account | CHI Conferences | Subscribe |
Sales Contacts
For advertising information contact:

Alan El Faye
VP, Advertising Sales - CA, Western US, Canada, Pacific Rim
213-300-3886

Kay O. Christopher
Regional Sales Manager, Advertising Sales -New England, North Eastern US
860-693-2991

Tom Loughran
Regional Sales Manager, Advertising Sales -Midwest, South Eastern US, Europe
781-972-5482

Link to Us!
You are welcome to link to articles on our website. Contact Catherine Varmazis for details.

e-Prints & Reprints
To post a full article from eCliniqua or Bio-IT World on your website (not just a link), or for paper reprints, please contact:
Ashley Zander

The YGS Group
717-399-1900 ext.125

IN THIS ISSUE

BRIDG Moves Toward Double Layer of Semantics

Clarix IRT Becomes Property of Phase Forward
Pain Relief Studies Drive Growth of Lifetree Clinical Research
News Briefs

STANDARDS
BRIDG Moves Toward Double Layer of Semantics
By Deborah Borfitz

Subject matter experts and information technology (IT) professionals involved in clinical trials should both be happier with the next release of BRIDG (Biomedical Research Integrated Domain Group), the domain analysis model aimed at synchronizing semantics within the clinical research and healthcare enterprises. Semantically speaking, BRIDG will be taking a “two-layer approach” that incorporates accepted clinical terminology and definitions as well as technical representations around which software programs and messages can be written.

So says Julie Evans, senior director of technical services at the Clinical Data Interchange Standards Consortium (CDISC). Five years ago, CDISC initiated construction of BRIDG to support harmonization of its own set of standards as well as to “interface more cleanly” with Health Level Seven (HL7), the standards-settings organization for electronic interchange of clinical, financial, and administrative information among healthcare-oriented computer systems. Since then, the National Cancer Institute (NCI), Food and Drug Administration (FDA), and HL7’s Regulated Clinical Research Information Management (RCRIM) Working Group have joined the effort. Read more.

ACQUISITIONS
Clarix IRT Becomes Property of Phase Forward

By Deborah Borfitz

Responding to intense interest among study sponsors and investigative sites for consolidated technologies, Phase Forward invested $40 million in cash to acquire privately held Clarix LLC in early September. The move tightly integrates Phase Forward’s flagship InForm electronic data capture (EDC) system with Clarix’s interactive response technology (IRT), which has done more than its competitors to augment the traditional telephone interface with the power of the Web.

So says Phase Forward Vice President Martin Young, noting that the company has worked with more than 10 different IRT providers across roughly 100 clinical trials. That Clarix has a fully Web-integrated model for subject randomization, predictive medication inventory management, and operational management and reporting is only one of its chief attributes. Clarix also allows clinical teams to build their own ad hoc reports during the course of a trial and not just use the standard, preconfigured ones. Read more.

CORPORATE PROFILE
Pain Relief Studies Drive Growth of Lifetree Clinical Research

By Deborah Borfitz

Lifetree Clinical Research has come a long way in a short time. When the Salt Lake City, UT-based clinical research organization (CRO) launched in March 2003, it offered only investigative site services at a small, private pain clinic. Co-owners Lynn Webster, MD, and Alice Jackson, RN, each put up less than $100,000 to begin operations. Within its first year of business, Lifetree was generating enough profits to build a free-standing clinical research facility where Webster’s pain clinic would co-locate, says Jackson, Lifetree’s CEO.

Client demand quickly transformed Lifetree into a “specialized research organization,” says Jackson, who has been doing analgesia studies for 20 years. “In our business plan, we never dreamed we would offer full-service CRO services within five years. We started small and put good processes and quality initiatives in place,” including training curriculum and standard operating procedures governed by FDA regulations. Read more.

News Briefs - Sept. 29, 2008

  • CDISC awarded contract for training of FDA reviewers
  • Nextrials expands its executive team
  • ACORN appoints Tara Webb senior director of CRO business development
  • Good Products and Adlib Software partner in pharmaceutical regulatory submissions
  • Paradigm Spine to implement PharmaPros’ automated trial management solution . . . more

LIFE SCIENCE JOBS

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics,
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit:
LSCDD

Lilly Singapore Center for Drug Discovery (LSCDD)- Senior Bioinformatics Scientist,
Contribute to the development of novel algorithms, data analysis methods and software tools for drug discovery as part of the Integrative Computational Sciences (ICS) department at LSCDD. Work closely with informatics and software engineering peers at ICS, and collaborate with the Discovery IT organization in Europe and USA. The successful candidate will offer hands-on insight and expertise in tailored therapeutic informatics and statistical analyses at the post-genomic era. For additional information, or to apply visit:
LSCDD

Lilly Singapore Center for Drug Discovery (LSCDD) - Manager, Software Engineering (Integrative Computational Sciences)
Join the Integrative Computational Sciences (ICS) department at Lilly Singapore Centre for Drug Discovery (LSCDD),as Manager Software Engineering. Lead the development of integrated applications to process and visualize data from cutting edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. Masters in Computer Science/Engineering or related discipline, 10+ years post graduation experience , 2 years management experience needed. For a complete job description and requirements or to apply visit:
LSCDD

Lilly Singapore Center for Drug Discovery(LSCDD) -Senior Software Engineer,
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit:
LSCDD
More Life Science Jobs ~ Add a Job Listing

FEATURED EVENTS

Harvard Biomed HPC Leadership Summit 2008, October 5~7, 2008, Boston, MA USA

Drug Stability Reporting (eStability) Working Group Vendor Meeting - October 7, 2008

DIA 2nd Annual Clinical Forum: Data Driven Drug Development Decisions October 20-23, 2008 | Ljubljana, Slovenia

The Fifteenth Annual Biopharmaceutical Applied Statistics Symposium - Nov 3-7,2008 ~Savannah, GA

Super Computing ~ November 15-21, Austin, TX

Fifth Annual Molecular Imaging Week ~November 17-19, 2008, La Jolla, CA,

The Next Tool for Healthcare Innovation~ Nov 20, 2008 2pm EST A Complimentary Frost & Sullivan eBroadcast

Barnett Educational Services

To have your event featured here, contact Lynn Cloonan for more information.

Email to a Friend
CALL FOR PROPOSALS

2009 Bio-IT World Conference & Expo

Clinical Research Professionals: We invite you to submit a speaking proposal for consideration by our Advisory Committee for the 7th Annual Bio-IT World Conference & Expo, April 27-29, 2009 at the World Trade Center in Boston, MA.

Track 5: Clinical and Medical Informatics – Will focus on the role of IT solutions, theoretical knowledge and social infrastructure in allowing for efficient gathering and analysis of clinical data. Details here.

Please submit proposals by October 15.

FEATURED CONTENT

Managed Innovation,
Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
sponsored by SAS


Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS Drug Development supports true innovation across the clinical trial process.
In this white paper you will learn how to:
~Assemble data to foster better collaboration
~Get up-to-date information during clinical trials
~Make informed decisions earlier in the trial process
Download now

Addressing Life Sciences Constantly Growing Data Challenges Research Environments sponsored by BlueArc

The continued explosion of raw experimental data, the increased use of video, the growingadoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.
Download this white paper to learn about:
• Factors driving the data explosion in the life sciences
• New data management issues that must be addressed
• HPC trends that are placing new demands on storage
• Storage solution attributes that address performance, manageability, and energy efficiency. Download now

“Storage for Science – Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments” sponsored by Isilon

Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics. Determining how best to manage those data stores has become a significant challenge for Researchers and IT Pros alike. This paper is intended to: Provide guidance on the many storage requirements common to Life Science research; Explain the evolution of modern storage architectures; Summarize the major data storage architectures currently in use. Additionally, it will present the Isilon IQ clustered storage product as a strong and flexible solution to those needs. Download now

Microsoft’s BioIT Alliance

Bio-IT World published a special supplement with support from Microsoft and their Alliance members. The supplement provides insight into the activities of the Alliance and their partners. Click here to access the Supplement PDF.

To have your white paper featured here, contact Lynn Cloonan for more information.

EXCLUSIVE WEBCAST

Life Science Webcasts from Bio-IT World and Cambridge Healthtech Media Group

Bio-IT World Expo
Video Highlights

Drug Discovery, Development and Commercialization: Evolving Challenges and Opportunities
Joshua Boger, PhD, president and CEO, Vertex Pharmaceuticals Inc., delivers his keynote at the 2008 Bio-IT World Conference & Expo in Boston, April 30, 2008.
View the webcast.

Personalized Genetics: Advancements and Driving Change
Linda Avey, co-founder of 23andMe, delivers her keynote at the 2008 Bio-IT World Conference & Expo in Boston, April 30, 2008.
View the webcast.

The Future of Personal Genomics
A distinguished panel of personal genomics experts discuss the future of personal genomics at the 2008 Bio-IT World Conference & Expo in Boston, April 30, 2008. They include Dietrich Stephan (co-founder, Navigenics); George Church (Harvard Medical School); Jeff Drazen (editor-in-chief, New England Journal Medicine); Fred Ledley (Bentley College); John Halamka (CIO, Harvard Medical School); and Linda Avey (23andMe). Bio-IT World Editor-in-Chief Kevin Davies moderates the discussion.
View the webcast.

Contact the Editors
Contributing Editor Deborah Borfitz covers development planning and protocol design; investigative site selection and management; and patient recruitment and retention.

Contributing Editor Ann Neuer covers project management, operations, and outsourcing, as well as data collection, data management, and electronic data capture. Ann has been writing in the clinical trials sector since 1995.

Web Editor Catherine Varmazis
manages and produces eCliniqua.
eCliniqua Archives

The Case for CROs in Emerging Markets
Sept. 15, 2008

More Archives.

Published by Cambridge Healthtech Media Group, division of CHI, Copyright © 2008; All rights reserved. eCliniqua may not be reproduced, electronically or in print, by any means, mechanical or electronic, in whole or in part, without written permission of Cambridge Healthtech Media Group, 250 First Ave., Suite 300, Needham, MA, 02494.
For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA 17601. Phone: 717-399-1900, ext. 125. Email: [email protected]